Corporate Information

Key Members

Alexei Gladkov President

1989: Received a Master’s degree in Philosophy from Novosibirsk University
2002: Received a Master’s degree in Business Administration in Moscow With over 28 years of International Business experience, 22 years were based actively in Japan. These included the fields of International Medical Tourism, Internet and Software Development, Biotechnology related development work and more.
2010: Personally, underwent bone marrow derived mesenchymal stem cell therapy and recognized its positive potential
2014: Established Kintaro Cells Power Co. Ltd in Japan based on advanced cell cultivation technology.

Ken Kobayashi CBO(Chief Branding Officer)

Worked at Dentsu Tech Inc. (currently Dentsu Promotion Plus Inc.) as a TV commercial production producer, e-CRM marketing producer, branding construction producer, and as a partner in branding and advertising strategies for major companies. Afterwards, he founded ALEX Co., Ltd., which operates an experiential sales and marketing business specializing in wealthy people. In 2017, he became CBO (Chief Branding Officer) of KINTARO Cells Power Co. Involved in brand strategy, product understanding, and promotion activities associated with global expansion.

Takatoshi Nakamura Chief of digitization and robotization department

Conducted research on artificial intelligence and cryptography at the MIT, U.S.A. Worked under Dr. Koichi Masubuchi and Dr. Marvin Minsky, and independently developed the next generation AI circuit “Cognitive Processor”. Later, he completed research on perfect cryptography in 2005, which was started by Dr. Claude Shannon in 1949 in the United States. He holds four graduate degrees from Keio University and Massachusetts Institute of Technology. After working at McKinsey & Company Japan, he was a Research Affiliate at the MIT from 1996 to 2014. He currently serves on the board of directors of Kintaro Okinawa Inc. and as Representative Director of the Research Institute of Information Security.

Hajime Tanaka Kintaro Companies Group Chief Financial Officer

In 1983, after passing the certified public accountant exam, he joined Tsuboi Kyodo Audit Office. In 1990, he became the head of the international department of Sanyu Audit Corporation, and later became the managing director of Sanyu BDO Consulting Co., Ltd. As a management consultant, he guides companies in preparing to go public. In 2002, he opened Aozora Certified Public Accountant Office and became its representative. Utilizing his comprehensive skills, he mainly provides guidance on hospital management. In 2013, he served as the general manager of Seikeikai Medical Corporation. Since 2022, he has been a full-time tax accountant for Kintaro Cells Power Co.

Kenji Yamamoto Security Department Manager

After entering Nihon University in 1983, he was active as a racer in the world of car racing (All Japan GT Championship, etc.) for 14 years. In 1997, he retired from racing and started a detective business in Naka-ku, Yokohama. Over the course of 27 years, he has experienced all kinds of investigations and is now in charge of the security department of the Kintaro Companies Group, utilizing his know-how. Since 2013, he has served as a director of the Japan Investigation Business Integrity Council. In August 2024, he will become the representative director of Kintaro Security Co., Ltd.

Nina Gladkov Medical Director (Doctor of Medicine)

In 1997, Dr. Nina Gladkova was assigned as the Chief Executive Officer of Novosibirsk Medical Clinic. Then, in 2001, she studied cell culture at the Biotechnology Institute in Russia. By 2009, Dr. Gladkova become the research director of I.C.I.D, designing and organizing workshops about utilizing Russian biotechnology, and human resource education. In 2013, she was involved in the research on practical application of cell culture as a medical director (of Medical Grid). Dr. Gladkova become the Medical Director of Kintaro Cells Power in 2014, and engaged in comprehensive research and laboratory management in practical field of regenerative medicine.